Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
Authors : Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, Glas AM, Witteveen A, Cardoso F, Piccart-Gebhart M, Esserman LJ, Poncet C, van t Veer LJ
Year : 2022
Journal : J Clin Oncol
Pages : JCO2102019